EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma


Lancet 1(8278): 935-937
Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma
The 2-component hypothesis of acute inflammation postulates that the acute inflammatory response depends on increased local blood flow and increased microvascular permeability; the validity of this concept, previously established in animals, was tested in man. A mixture of the mediators prostaglandin E2 and bradykinin produces a larger cutaneous wheal (volume) response than can be accounted for by summation of the responses to the individual substances or by the slopes of their dose-response curves. This enhanced response is inhibited by noradrenaline [norepinephrine] (consistent with the vasoconstrictor property of noradrenaline) and by salbutamol (consistent with the antipermeability property of salbutamol). The 2-component hypothesis of acute inflammation may apply to man as well as animals; this finding is important in the evaluation of the role of putative mediators in the pathogenesis of asthma and other diseases in which inflammation plays a part.

Accession: 005411011

PMID: 6122773

DOI: 10.1016/S0140-6736(82)91935-3

Download PDF Full Text: Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma



Related references

Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. Journal of Allergy and Clinical Immunology 88(4): 649-660, 1991

Association of the TNF-alpha-308 polymorphism with self-reported history of childhood asthma and evidence for a putative interaction with the ACE I/D polymorphism in asthma susceptibility. Journal of Medical Genetics 37(Supplement 1): S69, September, 2000

Synergistic interaction between choline and aspirin against acute inflammation induced by carrageenan and lipopolysaccharide. International Immunopharmacology 20(1): 229-237, 2014

Involvement of soluble mediators of inflammation in the pathogenic agent interaction--immune system in acute bacterial meningitis. Bacteriologia, Virusologia, Parazitologia, Epidemiologia 53(2): 89-97, 2010

Synergistic anti-inflammatory interaction between meloxicam and aminoguanidine hydrochloride in carrageenan-induced acute inflammation in rats. Life Sciences 78(10): 1044-1048, 2005

Interactions of substance P with putative mediators of inflammation and ATP. European Journal of Pharmacology 44(1): 45-49, 1977

Leukotrienes as mediators of asthma and inflammation. 1994

Inflammation mediators in asthma treatment. Pneumonologia i Alergologia Polska 70 Suppl 1: 66-72, 2003

Mast cell-dependent inflammatory mediators and their putative role in bronchial asthma. Clinical Science 68(2): 103-112, 1985

The influence of chemical mediators of acute inflammation on the cells of a subacute inflammation. Agents and Actions 3(5): 317-322, 1973